The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns
Arthritis Rheumatol
.
2014 Oct;66(10):2649-56.
doi: 10.1002/art.38776.
Authors
Atul Deodhar
1
,
John D Reveille
,
Filip van den Bosch
,
Jürgen Braun
,
Ruben Burgos-Vargas
,
Liron Caplan
,
Daniel O Clegg
,
Robert A Colbert
,
Lianne S Gensler
,
Désirée van der Heijde
,
Irene E van der Horst-Bruinsma
,
Robert D Inman
,
Walter P Maksymowych
,
Philip J Mease
,
Siba Raychaudhuri
,
Andreas Reimold
,
Martin Rudwaleit
,
Joachim Sieper
,
Michael H Weisman
,
Robert B M Landewé
Affiliation
1
Oregon Health & Science University, Portland.
PMID:
25154344
DOI:
10.1002/art.38776
No abstract available
MeSH terms
Humans
Spondylarthritis / diagnosis*
Spondylarthritis / drug therapy*
United States
United States Food and Drug Administration